This company seems to have been delisted
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
ImmunoGen
IMGN
C$42.61
Share price
0.00%
Change (1 day)
133.56%
Change (1 year)
Categories
ImmunoGen (IMGN) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : C$0.35 Billion
According to ImmunoGen 's latest financial reports the company's total liabilities are C$0.35 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ImmunoGen - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | C$0.26 B | 2.71% |
| 2021-12-31 | C$0.25 B | -24.64% |
| 2020-12-31 | C$0.33 B | -16.76% |
| 2019-12-31 | C$0.40 B | 4.97% |
| 2018-12-31 | C$0.38 B | -1.41% |
| 2017-12-31 | C$0.39 B | |
| 2016-06-30 | C$0.46 B | 37.47% |
| 2015-06-30 | C$0.34 B | 256.37% |
| 2014-06-30 | C$95.63 M | -0.86% |
| 2013-06-30 | C$96.45 M | -1.75% |
| 2012-06-30 | C$98.17 M | 31.14% |
| 2011-06-30 | C$74.86 M | 101.11% |
| 2010-06-30 | C$37.22 M | -4.29% |
| 2009-06-30 | C$38.89 M | 36.16% |
| 2008-06-30 | C$28.56 M | 22.37% |
| 2007-06-30 | C$23.34 M | -3.47% |
| 2006-06-30 | C$24.18 M | -16.37% |
| 2005-06-30 | C$28.91 M | -14.83% |
| 2004-06-30 | C$33.94 M | 64.14% |
| 2003-06-30 | C$20.68 M | -23.96% |
| 2002-06-30 | C$27.19 M | 7.41% |
| 2001-06-30 | C$25.32 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | C$1.47 B | 316.05% | 🇺🇸 USA |
 Amgen AMGN | C$113.47 B | 31,822.61% | 🇺🇸 USA |
 Eli Lilly LLY | C$100.34 B | 28,130.55% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | C$102.30 B | 28,682.17% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$157.68 B | 44,260.76% | 🇺🇸 USA |
 Pfizer PFE | C$160.18 B | 44,962.86% | 🇺🇸 USA |
 Novartis NVS | C$83.90 B | 23,503.77% | 🇨🇭 Switzerland |
 Sanofi SNY | C$84.84 B | 23,769.18% | 🇫🇷 France |